Bio

Sergey Jakimov is a founding partner of LongeVC, a venture capital fund supporting early-stage biotech and longevity-focused founders that are changing the world. I am a serial entrepreneur, having co-founded 3 deep-tech ventures and raised more than $40 million in venture funding for my own ventures and as an entrepreneur in residence. I have worked with several other early-stage companies in the therapeutics space on fundraising, IP protection, and clinical trial strategies, focusing on early treatments in cardiovascular, oncology, and neurodegenerative spaces. I am also a Visiting Lecturer to several universities on venture capital and intellectual property rights and I co-authored a master's program in Technology Law for the Riga Graduate School of Law. Since 2018, I have co-founded medical tech startup Longenesis, a cutting-edge company that unlocks the hidden value of biomedical data and accelerates novel drug treatment & discovery. In 2020 I co-founded LongeVC - a Venture Capital supporting early-stage biotech and longevity-focused founders that are changing the world. In 2021 I co-founded the Longevity Science Foundation - a non-profit organization advancing the field of human longevity by funding research and development of medical technologies to extend the healthy human lifespan. I hold a BSc in International Affairs from Rīga Stradiņš University and two MSc in Political Science and Government and Law and Finance from Central European University and Riga Graduate School of Law, respectively. I was named Forbes Latvia 30 Under 30 in technology and healthcare in 2020.